🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Dexmedetomidine Versus Dexamethasone as Adjuvants to Bupivacaine in Caudal Epidural Block

RecruitingNAAges 2 Years - 6 YearsAllSohag University
NCT07056244 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

The goal of This prospective, randomized, double-blind comparative study is to compare the efficacy of dexamethasone and dexmedetomidine as adjuvants to bupivacaine 0.125% in caudal epidural block for pediatrics undergoing inguinal hernia surgery, aged 2-6 years. of Both sex.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Children aged 2-6 years. * Both sexes. * American Society of Anesthesiologists (ASA) physical status I and II. * Scheduled for inguinal hernia surgery Exclusion Criteria: * Parents or legal guardians refusal. * Known hypersensitivity to any study drugs. * Abnormal sacral anatomy * Local infection at the injection site. * Neurological disease. * Coagulopathy. * Mental retardation.
💊

What it tests

  • Dexmedetomidine
  • Dexamethasone
📍

Where

1 site
Sohag university Hospital
Sohag, Egypt
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy